• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Weekly Roundup: January 29-February 2


ICYMI, this week we had news about VENT-03's potential as a small molecule therapeutic in dermatology, a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum, and more.

POLL: Are You Attending IMCAS World Congress 2024?

Let us know if you plan to attend IMCAS World Congress 2024.

Efinaconazole Demonstrates Superior Transungual Penetration Compared to Other Antifungal Treatments

Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.

Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin Disorders

Marcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.

Verrica Receives Permanent J-Code for Ycanth for Molluscum Contagiosum

The Centers for Medicare & Medicaid Services has issued a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum.

Is CPS the Solution for Refractory Plantar Warts?

An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.

Dupilumab Plus Antihistamines Beats Antihistamines Alone in Treating CSU

Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.

Discovering Dermatology Times: January 2024 Topical Treatments for Vitiligo Supplement

Learn more about the in-depth topics covered in the January 2024 topical treatments for vitiligo supplement of Dermatology Times.

Previewing Editorial Advisory Board Member Sessions at IMCAS World Congress 2024

Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.

Psychological Stress Exacerbates Brain Activities in Female Patients With Atopic Dermatitis

Functional magnetic resonance imaging response was utilized to test motor, somatosensory association cortex, perception, and sensory integration processing in a recent study.

Vitiligo and Retinal Detachment: Is There a Connection?

People with vitiligo face a higher risk of retinal detachment, according to a study in Taiwan.

New Molecule Shows Promise in Treating Atopic Dermatitis and Inflammatory Bowel Disease

Positive results in preclinical animal trials of DPT0218 may lead to advances in clinical treatment of autoimmune diseases.

Discovering Dermatology Times: January 2024

Learn more about the in-depth topics covered in the January 2024 print issue of Dermatology Times.

Dermatology Times January 2024 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Almirall Announces Partnership With Microsoft for Digital Transformation, Development of Skin Disease Treatments

The 3-year partnership and collaboration will employ the use of generative artificial intelligence and analytics technologies.

Interview Intersection: Expert Interviews From January 2024

Dermatology Times is recapping our top expert interviews from the month of January.

Glynis Ablon, MD, Previews IMCAS World Congress 2024

Ablon’s session highlights include best practices for hair restoration.

Clinical Characteristics of Melanoma in Black Patients Identified

A new report looking at melanoma in Black patients adds much-needed clinical insights.

An OTC Moisturizer’s Effects on Skin Ceramide Levels

An OTC moisturizer was found to improve skin ceramide levels in patients with eczema-prone skin.

Dermatology Conferences and Meetings Calendar 2024: February

Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.

Line-Field Confocal Optical Coherence Tomography Exhibits Highest Sensitivity and Negative Predictive Value in Onychomycosis

LC-OCT demonstrated higher sensitivity and negative predictive value compared to other methods of diagnosis and detection.

Topical Treatments, Minoxidil Solutions Found Most Effective in Wide Review of Pediatric Alopecia Therapies

Researchers in China reviewed topical modalities, minoxidil solutions, tofacitinib, and microneedling for pediatric AA.

Measuring the Economic Burden for Patients With Vitiligo

People with vitiligo in the US face burdensome health care expenses, including expenses seemingly unrelated to the condition, according to 1 study.

A Step Toward Overcoming a Melanoma Drug Resistance Pathway

Researchers have identified an epigenetic pathway involved in resistance to mitogen-activated protein kinase inhibitors, pointing the way to better patient treatment for resistant melanomas.

Telemedicine Demonstrates Equal Efficacy as In-Person Visits for Atopic Dermatitis

In a review of relevant research, investigators found that in many aspects, telemedicine services were as effective as in-office care visits for AD.

AAD Releases Updated Guidelines for the Management of Acne Vulgaris

The guidelines update the American Academy of Dermatology’s 2016 recommendations for acne management in adults, adolescents, and children aged 9 and older.

Key Considerations for Dermatology Practices Investing in New Equipment

Although new equipment can enhance the capabilities and profitability of a dermatology practice, the decision to make such an investment is a significant one.

Safety Razors Demonstrate Lower Incidence of Erythema, Multispectral Near-Infrared Spectroscopy Finds

Compared with cartridge razors, safety razors demonstrated a lower incidence of erythema.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.